Use of Substituted 8-Perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] Pyrimidin-4-one Derivatives as Therapeutic Agents
    5.
    发明申请
    Use of Substituted 8-Perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] Pyrimidin-4-one Derivatives as Therapeutic Agents 失效
    使用取代的8-全氟烷基-6,7,8,9-四氢嘧啶并[1,2-a]嘧啶-4-酮衍生物作为治疗剂

    公开(公告)号:US20070191384A1

    公开(公告)日:2007-08-16

    申请号:US11696256

    申请日:2007-04-04

    IPC分类号: A61K31/519

    CPC分类号: A61K31/519 C07D487/04

    摘要: The invention relates to use of a substituted-pyrimidone derivative represented by formula (I) or a salt thereof: wherein X, Y, R1, R2, R3, R4, R5, n, p and q are as described herein for treating a variety of disease states. More specifically, the invention relates to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of GSK3β, such as Pick's disease.

    摘要翻译: 本发明涉及由式(I)表示的取代嘧啶酮衍生物或其盐的用途:其中X,Y,R 1,R 2,R 3,R 4,R 5,n,p和q如本文所述用于处理多种 的疾病状态。 更具体地,本发明涉及包含所述衍生物或其盐作为活性成分的药物,其用于预防和/或治疗由GSK3β的异常活性如皮克病引起的疾病。

    USE OF 8-SUBSTITUTED-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
    8.
    发明申请
    USE OF 8-SUBSTITUTED-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES 失效
    使用8-取代-6,7,8,9-四氢嘧啶并[1,2-a]嘧啶-4-酮衍生物

    公开(公告)号:US20080021046A1

    公开(公告)日:2008-01-24

    申请号:US11764374

    申请日:2007-06-18

    CPC分类号: A61K31/519 C07D487/04

    摘要: The invention relates to use of substituted-pyrimidone derivatives represented by formula (I) or a salt thereof: wherein X, Y, R1, R2, R3, R4, R5, n, p and q are as defined herein. More specifically, the invention relates to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of GSK3β, such as Pick's disease among various other diseases as claimed herein.

    摘要翻译: 本发明涉及由式(I)表示的取代嘧啶酮衍生物或其盐的用途:其中X,Y,R 1,R 2,R 3,R 4,R 5,n,p和q如本文所定义。 更具体地,本发明涉及包含所述衍生物或其盐作为活性成分的药物,其用于预防和/或治疗由GSK3β的异常活性引起的疾病,例如各种其他疾病中的皮克病,例如 在此。